|
|
Volumn 29, Issue 1-2, 1997, Pages 654-655
|
|
Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: A multi-center report
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADULT;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
DRUG EFFICACY;
EPSTEIN BARR VIRUS;
FEMALE;
GASTROINTESTINAL TOXICITY;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
LYMPHOPROLIFERATIVE DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PANCREAS TRANSPLANTATION;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RECIPIENT;
ADULT;
DRUG THERAPY, COMBINATION;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
KIDNEY TRANSPLANTATION;
MALE;
MYCOPHENOLIC ACID;
PANCREAS TRANSPLANTATION;
PATIENT SELECTION;
POSTOPERATIVE COMPLICATIONS;
QUESTIONNAIRES;
RETROSPECTIVE STUDIES;
TACROLIMUS;
|
|
EID: 0030905149
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(96)00383-1 Document Type: Conference Paper |
|
Times cited : (76)
|
|
References (2)
|
